View of Evidence-based Colombian consensus and expert opinion regarding the use of sodium-glucose cotransporter type 2 (iSGLT-2) inhibitors in the cardiorenal continuum in patients with chronic kidney disease | Revista Colombiana de Nefrología

← Evidence-based Colombian consensus and expert opinion regarding the use of sodium-glucose cotransporter type 2 (iSGLT-2) inhibitors in the cardiorenal continuum in patients with chronic kidney disease